End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.99 CNY | +0.49% | -1.02% | -25.94% |
09-06 | Gan & Lee Pharmaceuticals. announces an Equity Buyback for CNY 300 million worth of its shares. | CI |
09-05 | Gan & Lee Pharmaceuticals. authorizes a Buyback Plan. | CI |
Chart calendar Gan & Lee Pharmaceuticals.
Upcoming events on Gan & Lee Pharmaceuticals.
Past events on Gan & Lee Pharmaceuticals.
28/08/2024 | Q2 2024 Earnings Release |
16/05/2024 07:00 | Annual General Meeting |
24/04/2024 | Q1 2024 Earnings Release |
24/04/2024 | Q4 2023 Earnings Release |
11/03/2024 05:00 | Extraordinary Shareholders Meeting |
30/10/2023 | Q3 2023 Earnings Release |
11/09/2023 07:00 | Extraordinary Shareholders Meeting |
24/08/2023 | Q2 2023 Earnings Release |
27/04/2023 | Q1 2023 Earnings Release |
19/04/2023 | Annual General Meeting |
30/03/2023 | Q4 2022 Earnings Release |
13/03/2023 06:00 | Extraordinary Shareholders Meeting |
15/11/2022 06:00 | Extraordinary Shareholders Meeting |
27/10/2022 | Q3 2022 Earnings Release |
25/08/2022 | Interim 2022 Earnings Release |
19/05/2022 07:00 | Annual General Meeting |
27/04/2022 | Q1 2022 Earnings Release |
27/04/2022 | FY 2021 Earnings Release |
27/10/2021 | Q3 2021 Earnings Release |
19/10/2021 07:00 | Extraordinary Shareholders Meeting |
Past dividends on Gan & Lee Pharmaceuticals.
17/06/2024 | Annual 0.2 CNY |
19/06/2022 | Annual 0.3 CNY |
20/05/2021 | Annual 0.4 CNY |
19/08/2020 | Annual 0.5 CNY |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 3 612 3 786 -4.59% | 0,00 | 2 608 2 585 0.88% | 3 511 | 4 458 | 5 419 |
EBITDA Million CNY | Released Forecast Spread | 0,00 0,00 - | 0,00 | 538 584 -7.93% | 922 | 1 520 | 1 943 |
EBIT Million CNY | Released Forecast Spread | 1 699 1 694 0.29% | 0,00 | 315 413 -23.66% | 783 | 1 339 | 1 774 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 1 696 1 687 0.53% | 0,00 | 306 417 -26.58% | 778 | 1 337 | 1 772 |
Net income Million CNY | Released Forecast Spread | 1 453 1 436 1.17% | -440 | 340 322 5.73% | 690 | 1 153 | 1 543 |
EPS CNY | Released Forecast Spread | 2,59 2,56 1.17% | -0,78 | 0,60 0,53 13.21% | 1,15 | 1,93 | 2,58 |
Announcement Date | 27/04/22 | 30/03/23 | 24/04/24 | - |
Quarterly results
Fiscal Period | Juni | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 702 699 0.51% | 560 654 -14.29% | 755 792 -4.78% | 1 029 | 1 452 | 673 | 951 | |
EBIT Million CNY | Released Forecast Spread | -1,93 | 113 | 226 | |||||
Net income Million CNY | Released Forecast Spread | 132 | |||||||
EPS CNY | Released Forecast Spread | 0,23 | 0,13 0,08 62.5% | 0,16 0,23 -30.43% | 0,35 0,35 0% | 0,24 | 0,50 | 0,30 | 0,39 |
Announcement Date | 30/10/23 | 24/04/24 | 24/04/24 | 28/08/24 | - | - | - | - |
Past sector events for Gan & Lee Pharmaceuticals.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603087 Stock
- Calendar Gan & Lee Pharmaceuticals.
MarketScreener is also available in this country: United States.
Switch edition